` IVF (INVO Fertility Inc) vs S&P 500 Comparison - Alpha Spread

IVF
vs
S&P 500

Over the past 12 months, IVF has underperformed S&P 500, delivering a return of -88% compared to the S&P 500's 9% growth.

Stocks Performance
IVF vs S&P 500

Loading
IVF
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
IVF vs S&P 500

Loading
IVF
S&P 500
Difference
www.alphaspread.com

Performance By Year
IVF vs S&P 500

Loading
IVF
S&P 500
Add Stock

Competitors Performance
INVO Fertility Inc vs Peers

INVO Fertility Inc
Glance View

Market Cap
2.7m USD
Industry
Health Care

INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.

IVF Intrinsic Value
7.81 USD
Undervaluation 84%
Intrinsic Value
Price
Back to Top